Form 4: Marilyn Nelson Exercises Stock Options in Inspire Medical Systems

Sentiment:

SEC Form 4 Filing


Director Marilyn Nelson exercised stock options and acquired shares of Inspire Medical Systems, Inc. on March 1, 2024.

Summary

  • On March 1, 2024, Marilyn Nelson, a director of Inspire Medical Systems, Inc., exercised stock options to acquire 2,555 shares of common stock at a price of $0.94 per share.
  • Following the transaction, Ms. Nelson directly owns 27,822 shares of common stock.
  • Ms. Nelson also indirectly owns 50,919 shares through GDN Holdings, LLC, where she is the managing member.
  • The exercised stock options were fully vested and exercisable as of March 1, 2024, with an original expiration date of April 1, 2027.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The exercise of options could be seen as a positive, but it's not a major event.

Positives

  • The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the actions of company directors.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.

Key Dates

DateDescription
03/01/2024Date of transaction: Marilyn Nelson exercised stock options and acquired shares.
04/01/2027Expiration date of the stock options exercised.
03/05/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.